Bristol-Myers Squibb Dirección
Dirección controles de criterios 3/4
El CEO de Bristol-Myers Squibb's es Chris Boerner , nombrado en Nov 2023, tiene una permanencia de menos de un año. compensación anual total es $8.46M, compuesta por 14.9% salario y 85.1% primas, incluidas acciones y opciones de la empresa. posee directamente un 0.005% de las acciones de la empresa, por valor de $4.95M. La antigüedad media del equipo directivo y de la junta directiva es de 2.3 años y 4.4 años, respectivamente.
Información clave
Chris Boerner
Chief Executive Officer (CEO)
US$8.5m
Compensación total
Porcentaje del salario del CEO | 14.9% |
Permanencia del CEO | less than a year |
Participación del CEO | 0.005% |
Permanencia media de la dirección | 2.3yrs |
Promedio de permanencia en la Junta Directiva | 4.4yrs |
Actualizaciones recientes de la dirección
Recent updates
Is Bristol Myers Squibb A Buy At These Bottom Levels?
Apr 22Bristol Myers Squibb: Seriously Undervalued At Peak Pessimism (Rating Upgrade)
Apr 12Bristol-Myers Squibb Is A Speculative Buy On Price Action (Technical Analysis)
Apr 02Bristol-Myers Squibb (NYSE:BMY) Is Due To Pay A Dividend Of $0.60
Mar 21Bristol-Myers Squibb Is Not A Buy For Me
Mar 19Bristol-Myers Squibb: Compelling Value From The New Products Portfolio And 4.5% Yield
Mar 07Bristol-Myers Squibb (NYSE:BMY) Is Due To Pay A Dividend Of $0.60
Mar 07We Think Bristol-Myers Squibb's (NYSE:BMY) Healthy Earnings Might Be Conservative
Feb 20Bristol-Myers Squibb Company (NYSE:BMY) Just Released Its Annual Results And Analysts Are Updating Their Estimates
Feb 06Bristol-Myers Squibb: Massive Discount Spells Opportunity
Feb 04BMY: Might Be Approaching A Bottom In 2024
Jan 23Investors Aren't Entirely Convinced By Bristol-Myers Squibb Company's (NYSE:BMY) Earnings
Jan 16Bristol-Myers Squibb: I Went Looking For Value And Found A 4.63% Yield Also
Jan 10Bristol-Myers Squibb's Winning Formula: Dividends, M&A, And Innovation
Dec 31Bristol-Myers Squibb (NYSE:BMY) Has Announced That It Will Be Increasing Its Dividend To $0.60
Dec 26Bristol Myers Squibb: This Dividend Contender Is A Steal Right Now
Dec 19Bristol-Myers Squibb: A Nice Deal For This Bargain Pharma Stock
Dec 12Bristol-Myers Squibb (NYSE:BMY) Is Increasing Its Dividend To $0.60
Dec 11Bristol-Myers Squibb: The Patent Expiry Challenge
Nov 23Bristol Myers Squibb: Bright Future Ahead
Nov 17Bristol-Myers Squibb (NYSE:BMY) Has A Pretty Healthy Balance Sheet
Nov 08Análisis de compensación del CEO
Fecha | Compensación total | Salario | Ingresos de la empresa |
---|---|---|---|
Mar 31 2024 | n/a | n/a | -US$6b |
Dec 31 2023 | US$8m | US$1m | US$8b |
Sep 30 2023 | n/a | n/a | US$8b |
Jun 30 2023 | n/a | n/a | US$8b |
Mar 31 2023 | n/a | n/a | US$7b |
Dec 31 2022 | US$7m | US$1m | US$6b |
Sep 30 2022 | n/a | n/a | US$7b |
Jun 30 2022 | n/a | n/a | US$7b |
Mar 31 2022 | n/a | n/a | US$6b |
Dec 31 2021 | US$7m | US$1m | US$7b |
Sep 30 2021 | n/a | n/a | -US$5b |
Jun 30 2021 | n/a | n/a | -US$5b |
Mar 31 2021 | n/a | n/a | -US$6b |
Dec 31 2020 | US$6m | US$953k | -US$9b |
Sep 30 2020 | n/a | n/a | -US$44m |
Jun 30 2020 | n/a | n/a | -US$563m |
Mar 31 2020 | n/a | n/a | US$954m |
Dec 31 2019 | US$6m | US$891k | US$3b |
Compensación vs. Mercado: La compensación total de Chris($USD8.46M) está por debajo de la media de empresas de tamaño similar en el mercado US ($USD13.51M).
Compensación vs. Ingresos: La compensación de Chris ha aumentado mientras la empresa no es rentable.
CEO
Chris Boerner (52 yo)
less than a year
Permanencia
US$8,461,833
Compensación
Dr. Christopher S. Boerner, also known as Chris, Ph.D. served as Chief Operating Officer at Bristol-Myers Squibb Company since April 26, 2023 to 2023 and served as its Executive Vice President since April...
Equipo directivo
Nombre | Posición | Permanencia | Compensación | Propiedad |
---|---|---|---|---|
CEO & Chairman | less than a year | US$8.46m | 0.0050% $ 4.5m | |
Executive VP & CFO | 4.4yrs | US$7.17m | 0.0096% $ 8.8m | |
Executive VP & General Counsel | 17.2yrs | US$5.92m | 0.022% $ 20.1m | |
Executive VP | 4.8yrs | US$6.23m | 0.0030% $ 2.7m | |
Executive VP and Chief Digital & Technology Officer | 2.3yrs | sin datos | 0.00026% $ 236.4k | |
VP & Head of Investor Relations | no data | sin datos | sin datos | |
Chief Compliance & Ethics Officer | less than a year | sin datos | sin datos | |
Executive Vice President & Chief Human Resources Officer | less than a year | sin datos | 0.00013% $ 118.2k | |
Head of Medical Affairs | no data | sin datos | sin datos | |
Executive VP | no data | sin datos | 0.00080% $ 727.3k | |
Senior Vice President of Major Markets | no data | sin datos | sin datos | |
Executive Vice President of Global Product Development & Supply | 2.3yrs | sin datos | 0.00030% $ 272.7k |
2.3yrs
Permanencia media
53yo
Promedio de edad
Equipo directivo experimentado: El equipo directivo de BMY se considera experimentado (2.3 años antigüedad media).
Miembros de la Junta
Nombre | Posición | Permanencia | Compensación | Propiedad |
---|---|---|---|---|
CEO & Chairman | 1.3yrs | US$8.46m | 0.0050% $ 4.5m | |
Independent Director | 12.3yrs | US$357.50k | 0% $ 0 | |
Independent Director | 3.6yrs | US$375.00k | 0% $ 0 | |
Independent Director | 4.4yrs | US$365.00k | 0% $ 0 | |
Independent Director | 8yrs | US$359.68k | 0% $ 0 | |
Independent Director | 1.8yrs | US$329.97k | 0% $ 0 | |
Lead Independent Director | 7.2yrs | US$425.00k | 0.0018% $ 1.6m | |
Independent Director | 3.6yrs | US$365.00k | 0% $ 0 | |
Independent Director | 4.4yrs | US$371.68k | 0.00067% $ 609.1k | |
Independent Director | 6.3yrs | US$344.74k | 0% $ 0 | |
Independent Director | 2.8yrs | US$335.00k | 0% $ 0 |
4.4yrs
Permanencia media
62yo
Promedio de edad
Junta con experiencia: La junta directiva de BMY se considera experimentada (4.4 años de antigüedad promedio).